Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Endocrinol.

Sec. Clinical Diabetes

Mapping Sex-Based Multimorbidity Networks in Type 1 Diabetes: A Real-World Study from Shanghai

Provisionally accepted
Yuxuan  ShengYuxuan Sheng1Ping  HePing He2Junlei  SuJunlei Su1Zhongyun  ZhangZhongyun Zhang1Tingyu  ZhangTingyu Zhang1Haolei  PanHaolei Pan1Huayan  YaoHuayan Yao1Yanbin  XueYanbin Xue1Xueyuan  LiXueyuan Li3Bin  CuiBin Cui1Zizheng  ZhangZizheng Zhang1*Weiqiong  GuWeiqiong Gu1*
  • 1Shanghai Institute of Endocrine and Metabolic Disease, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
  • 2Shanghai Hospital Development Center, Shanghai, China
  • 3Wonders Information Co Ltd, Shanghai, China

The final, formatted version of the article will be published soon.

Background: Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disorder associated with a substantial metabolic burden. However, large-scale, real-world studies assessing sex-specific multimorbidity patterns in T1DM remain limited. Objective: To characterize the clinical profiles and multimorbidity patterns in patients with T1DM, using age-and sex-matched individuals with type 2 diabetes mellitus (T2DM) as controls. Methods: Using the Shanghai Hospital Link Database, we identified patients aged 10–79 years with a first T1DM-coded diagnosis between 2014 and 2023 and selected 1:1 sex-and index-age–matched T2DM controls. Clinical characteristics were compared between groups overall and stratified by sex. Sex-stratified multimorbidity networks were constructed and analyzed using standard network metrics. Subgroup-unique comorbid disease pairs were identified using the Salton Cosine Index. Results: We included 18,971 patients with T1DM and 18,971 matched T2DM controls. Compared with T2DM, T1DM showed shorter observed follow-up, higher glycated hemoglobin, higher high-This is a provisional file, not the final typeset article density lipoprotein cholesterol, and lower triglyceride, with more pronounced differences among females. Hypertension and dyslipidemia were the most central comorbidities across all networks, closely linked to cardiovascular and cerebrovascular conditions. The female T1DM network exhibited greater complexity and connectivity than the male T1DM network. Subgroup-unique pairs were more frequent in T1DM, including peripheral vascular disease–nonalcoholic fatty liver disease and diabetic eye complications–stroke in males, and neuropathy–osteoporosis, nephropathy–chronic gastritis, and chronic gastritis–asthma in females. Conclusion: We identified shared cardiometabolic comorbidities (hypertension and dyslipidemia) across diabetes types and sexes, and sex-specific multimorbidity co-occurrence signatures in T1DM. These findings support integrating blood pressure and lipid optimization with glycemic management, and underscore the need for sex-sensitive surveillance of subgroup-specific clusters, highlighting broader multisystem clustering in females and vascular-risk co-occurrence signals in males that may warrant intensified multifactorial atherosclerotic cardiovascular disease prevention.

Keywords: multimorbidity, Network analysis, Real-world data, sex differences, type 1 diabetes mellitus, type 2 diabetes mellitus

Received: 24 Sep 2025; Accepted: 02 Feb 2026.

Copyright: © 2026 Sheng, He, Su, Zhang, Zhang, Pan, Yao, Xue, Li, Cui, Zhang and Gu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Zizheng Zhang
Weiqiong Gu

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.